Author

Preston E. Girardot

Emory University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

Charles BrenneriD· 2 shared Jana T SellersiD· 2 shared Jeffrey H. BoatrightiD· 2 shared John M. NickersoniD· 2 shared Micah A. ChrenekiD· 2 shared Xian ZhangiD· 2 shared Ying Li· 2 shared Eldon E. GeisertiD· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Charles BrennerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintDec 3, 2024

Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model

Nan Zhang, Ying Li, Xian Zhang…·Jeffrey H. Boatright

This study shows that oral Nicotinamide Riboside (NR) treatment protects retinal ganglion cells (RGCs) and optic nerve axons in DBA/2J mice, likely through increased retinal NAD+ levels, and also prevents iris depigmentation and delayed IOP elevation.

2 citations

mouseexperimental assay

𝕏 PostBluesky

Molecular BiologyInvestigative Ophthalmology & Visual SciencePeer-reviewedAug 27, 2020

Systemic Treatment with Nicotinamide Riboside is Protective in Three Mouse Models of Retinal Degeneration

Xian Zhang, Nathaniel F. Henneman, Preston E. Girardot…·Jeffrey H. Boatright

This study shows that systemic NR treatment protects against retinal degeneration in three mouse models by preserving retinal function and structure and increasing NAD+ levels.

25 citations

mouseexperimental assay

𝕏 PostBluesky